Flavonoids and Their Anti-Diabetic Effects: Cellular Mechanisms and Effects to Improve Blood Sugar Levels.
Al-Ishaq RK, Abotaleb M, Kubatka P, Kajo K, Büsselberg D. · 2019
Read Flavonoids and Their Anti-Diabetic Effects: Cellular Mechanisms and Effects to Improve Blood Sugar Levels. by Al-Ishaq RK, Abotaleb M, Kubatka P, Kajo K, Büsselberg D. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6769509.txt.
Introduction
Al-Ishaq and co-authors review flavonoids and their anti-diabetic effects. Flavonoids are plant compounds found in fruits, vegetables, and fungi. They share a 15-carbon skeleton with two aromatic rings and fall into six subclasses. Diabetes, marked by high blood sugar, is a growing global burden. Lab and animal studies suggest flavonoids can help.
The review maps the pathways flavonoids act on. These include glucose transporters, liver enzymes, and the AMPK, PPAR, and NF-kB pathways. Through them, flavonoids may improve how diabetes develops and how its complications unfold. One compound, chrysin, eased nerve damage in diabetic rats and lowered inflammatory signals. The authors call flavonoids a promising support for blood sugar control.
Catalog record
| CREATOR | Al-Ishaq RK, Abotaleb M, Kubatka P, Kajo K, Büsselberg D. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 100 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Flavonoids and Their Anti-Diabetic Effects: Cellular Mechanisms and Effects to Improve Blood Sugar Levels By Raghad Khalid AL-Ishaq, Mariam Abotaleb, Peter Kubatka, Karol Kajo, Dietrich Büsselberg Published in: Biomolecules DOI: 10.3390/biom9090430 ABSTRACT Diabetes mellitus (DM) is a prevailing global health metabolic disorder, with an alarming incidence rate and a huge burden on health care providers. DM is characterized by the elevation of blood glucose due either to a defect in insulin synthesis, secretion, binding to receptor, or an increase of insulin resistance. The internal and external factors such as obesity, urbanizations, and genetic mutations could increase the risk of developing DM. Flavonoids are phenolic compounds existing as secondary metabolites in fruits and vegetables as well as fungi. Their structure consists of 15 carbon skeletons and two aromatic rings (A and B) connected by three carbon chains. Flavonoids are furtherly classified into 6 subclasses: flavonols, flavones, flavanones, isoflavones, flavanols, and anthocyanidins. Naturally occurring flavonoids possess anti-diabetic effects. As in vitro and animal model’s studies demonstrate, they have the ability to prevent diabetes and its complications. The aim of this review is to summarize the current knowledge addressing the antidiabetic effects of dietary flavonoids and their underlying molecular mechanisms on selected pathways: Glucose transporter, hepatic enzymes, tyrosine kinase inhibitor, AMPK, PPAR, and NF-κB. Flavonoids improve the pathogenesis of diabetes and its complications through the regulation of glucose metabolism, hepatic enzymes activities, and a lipid profile. Most studies illustrate a positive role of specific dietary flavonoids on diabetes, but the mechanisms of action and the side effects need more clarification. Overall, more research is needed to provide a better understanding of the mechanisms of diabetes treatment using flavonoids. 1. DIABETES AND FLAVONOIDS 1.1. Diabetes Mellitus Diabetes mellitus (DM) is one of the epidemics challenging public health problems throughout the world [1]. The prevalence rate of diabetes is increasing exponentially and the World Health Organization predicts that by the year 2030, diabetes is expected to be the seventh leading cause of death worldwide [2,3]. Diabetes mellitus is a metabolic disorder characterized by the elevation of blood glucose due to the defects in insulin action, secretion or both (insulin is insufficient or inefficient) [4]. Type 1, type 2, and gestational diabetes are the three main types of diabetes targeting children, adults, and pregnant women, respectively [5]. The internal and external factors such as obesity, urbanization, genetic mutations, and a lack of physical activities contribute to the pathogenesis of diabetes [6]. The symptoms and signs of diabetes include polyuria (frequent urination), polyphagia (increased hunger), polydipsia (increased thirst), weight loss, and unconsciousness [7]. Diabetes could lead to deleterious complications like nephropathy, atherosclerosis, and cardiac dysfunction and target major organs in the body such as heart, nerves, kidneys, eyes, and blood vessels [8]. The high mortality and morbidity rate of diabetes combined with the higher risk of bacterial or viral infections or the development of cancer is a major concern of the diseases epidemic [9]. While currently there is no cure, diabetes is successfully treated by managing a healthy lifestyle combined with the administration of anti-diabetic agents and hypoglycemic drugs such as sulphonylureas, thiazolidinediones (TZDs), and biguanides all of which reduce blood glucose [10]. 1.2. Glucose Homeostasis Following a carbohydrate rich meal, the level of glucose in the body is regulated by two primary hormones: Insulin and glucagon [11]. The digestion of most starch molecules occurs in the upper gastrointestinal tract where they get hydrolyzed into smaller molecules (monosaccharides) which are absorbed through glucose transporters (GLUT) into the blood stream [12]. The GLUT-family is encoded by SLC2 genes and is responsible to transport monosaccharide, polysaccharide, and other small compounds through the membrane [13]. Fourteen GLUT proteins are expressed in human; GLUT 1-12, GLUT 14, and a myo-inositol transporter (HMIT) [14]. GLUT 2 is responsible to transport glucose from the circulation to pancreatic β cells where it gets oxidized and leads to the secretion of insulin [11]. The reduction of blood glucose levels occurs through three main mechanisms: (i) The enhancement of a glucose uptake by peripheral tissues through the translocation of GLUT 4; (ii) the inhibition of lipolysis and the promotion of lipogenesis; and (iii) the promotion of glucose storage and utilization in the liver [11]. One the other hand, when the glucose level in the body is low, the level of glucagon secretion increases due to two mechanisms: (i) The promotion of glucose production and release in the liver and (ii) the promotion of lipolysis and releasing free fatty acids from adipose tissue [14,15]. 1.3. Insulin Resistance Insulin resistance is defined as an impaired sensitivity to insulin due to an increase insulin secretion [16]. The different mechanisms explain the causes of insulin resistance in diabetic patients are: abnormal insulin production; impaired post-receptor signaling (major cause); insulin receptor mutation; and the presence of an insulin antagonist in the body [17]. The defect in glucose uptake due to the down-regulation of GLUT 4 translocation is considered to be the primary metabolic abnormality in type 2 diabetes which occurs as a result of tyrosine phosphorylation inhibition of insulin receptor substrate (IRS-1) [18]. The inhibition of an insulin signaling pathway occurs due to increased phosphatase activities, such as protein tyrosine phosphatase (PTP1B) and tensin homologue (PTEN), which dephosphorylate signaling molecules and inhibit insulin signal [19]. Cell exposure to free fatty acids (FFAs) and tumor necrosis factor alpha (TNF-α) inhibit the phosphorylation of IRS-1 that inhibit insulin signaling and action [20]. A suppressor of cytokine signaling (SOCS-1 and 3) shows a different underlying mechanism which blocks the downstream insulin signaling pathway by competing with IRS-1 to associate with the insulin receptor (IR) [21]. The accumulation of lipids in skeletal muscle and liver activates the pathways which negatively affect an insulin signaling pathway resulting in the reduction in both glucose uptake by skeletal muscle and glycogen synthesis in the liver [22]. In order to combat insulin resistance, the body increases the production of insulin to maintain euglycemia leading to an increase in the size of islet cells and pancreatic β-cells [23]. 1.4. Insulin Release Defect in Diabetes Type 2 diabetes is characterized by the high glucose level in the blood (hyperglycemia), the alteration in β-cells size and function, and insulin resistance [24]. Apoptosis caused by lipotoxicity, intracellular and extracellular deposit of islets amyloid polypeptide (IAPP), and glucotoxicity decreases the β-cells size which alter their functions [25]. As Β-cell mass decreases and its functions reduces, the cells are unable to compensate for the higher demand of insulin secretion due to insulin resistance [26]. Chronic hyperglycemia caused by chronic over-nutrition has proven to induce β cells apoptosis by endoplasmic reticulum stress (ER), a high level of intracellular calcium, the production of reactive oxygen species (ROS), and oxidation stress [27]. A high level of FFAs could also stimulate pro-apoptotic effects on β-cells that diminish their functions [28]. 1.5. Lipogenesis Regulation in Adipocytes Adipocyte differentiation, cellular lipid droplets accumulation, and adipogenesis occur in the body due to adipocyte transcription factors, like peroxisome proliferator-activated receptor gamma (PPAR γ) and adipokines, such as resistin [29]. PPAR γ is a nuclear hormone receptor which is expressed mainly in the adipose tissue [30]. It is important in glucose homeostasis, insulin sensitivity, adipogenesis, and energy metabolism. It also is critical in inducing